Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Borneol extract (冰片提取物) is a preclinical-stage botanical extract and Traditional Chinese Medicine (TCM)-derived compound. It is primarily associated with Guangdong Jiaying Pharmaceutical and its partner Guangdong Huaqingyuan Biotech, which specializes in the cultivation of Cinnamomum burmannii, a plant with high natural borneol content. The active component, borneol, is a bicyclic monoterpenoid known for its anti-inflammatory, analgesic, and antibacterial properties. The extract is currently being investigated for its antibacterial applications against various bacterial infections, although its specific molecular mechanism of action remains undisclosed.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on borneol extract.